A Systematic Review of Recent Clinical Practice Guidelines on the Diagnosis, Assessment and Management of Hypertension

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Al Ansary, Lubna A ^a   Tricco, Andrea C ^b   Adi, Yaser ^a   Bawazeer, Ghada ^a,c   Perrier, Laure ^b   Al Ghonaim, Mohammed ^a   AlYousefi, Nada ^a   Tashkandi, Mariam ^d   Straus, Sharon E ^b,e  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIETARY INTAKE; EVOLUTIONARY ADAPTATION; EXERCISE; FAMILY HISTORY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE QUALITY; HUMAN; HYPERTENSION; LABORATORY TEST; LIFESTYLE MODIFICATION; MEDICAL HISTORY; METHODOLOGY; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PATIENT ATTITUDE; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW;

CARDIOVASCULAR DISEASES; GUIDELINE ADHERENCE; HUMANS; HYPERTENSION; PRACTICE GUIDELINES AS TOPIC; RISK;

EID: 84872579591     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053744     Document Type: Review

References (58)

1. WHO (2011) Global Atlas on cardiovascular disease prevention and control. Raised blood pressure (hypertension): A major risk factor of CVDs.
2. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, et al. (2009) Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 119: 480-486.
3. Law MR, Morris JK, Wald NJ, (2009) Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 338.
4. National Institute for Health and Clinical Excellence (2011) Cost-Effective Analysis- Pharmacological Treatment (Appendix I). The Clinical Management of Primary Hypertension in Adults (CG127). pp.421-445.
5. Cai L, Liu A, Zhang L, Li S, Wang P, (2011) Prevalence, Awareness, Treatment, and Control of Hypertension among Adults in Beijing, China. Clinical and Experimental Hypertension 0: 1-8.
6. Whelton PK, He J, Muntner P, (2004) Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens 18: 545-551.
7. Alsuwaida A, Alghonaim M, (2011) Gender Disparities in the Awareness and Control of Hypertension. Clinical and Experimental Hypertension 33: 354-357.
8. Wang YR, Alexander GC, Stafford RS, (2007) Outpatient Hypertension Treatment, Treatment Intensification, and Control in Western Europe and the United States. Arch Intern Med 167: 141-147.
9. Fervers B, Burgers JS, Haugh MC, Brouwers M, Browman G, et al. (2005) Predictors of high quality clinical practice guidelines: examples in oncology. International Journal for Quality in Health Care 17: 123-132.
10. Watine J, Friedberg B, Nagy E, Onody R, Oosterhuis W, et al. (2006) Conflict between Guideline Methodologic Quality and Recommendation Validity: A Potential Problem for Practitioners. Clinical Chemistry 52: 65-72.
11. Nagy E, Watine J, Bunting PS, Onody R, Oosterhuis WP, et al. (2008) Do Guidelines for the Diagnosis and Monitoring of Diabetes Mellitus Fulfill the Criteria of Evidence-Based Guideline Development? Clinical Chemistry 54: 1872-1882.
12. Pentheroudakis G, Stahel R, Hansen H, Pavlidis N, (2008) Heterogeneity in cancer guidelines: should we eradicate or tolerate? Annals of Oncology 19: 2067-2078.
13. Watine JC, Bunting PS, (2008) Mass colorectal cancer screening: Methodological quality of practice guidelines is not related to their content validity. Clinical Biochemistry 41: 459-466.
14. Grimshaw JM, Thomas RE, G M, C F, C R, et al. (2004) Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 8.
15. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, et al. (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 339: b2700.
16. The AGREE Research Trust (2009) Appraisal of Guidelines for Research and Evaluation II Instrument. In: Brouwers MC, editor.
17. Advanced Analytics L (2011) AgreeStat 2011.2 for MS Excel. In: Excel AfM, editor.
18. The Cochrane Collaboration (2011) Cochrane Hypertension Group.
19. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28: 1462-1536.
20. Mancia G, Laurent S, Agabiti-Rosei E, Ambrosioni E, Burnier M, et al. (2009) Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 27: 2121-2158.
21. Sanchez RA, Ayala M, Baglivo H, Velazquez C, Burlando G, et al. (2009) Latin American guidelines on hypertension. Latin American Expert Group. J Hypertens 27: 905-922.
22. Seedat YK, Croasdale MA, Milne FJ, Opie LH, Pinkney-Atkinson VJ, et al. (2006) South African hypertension guideline 2006. S Afr Med J 96: 337-362.
23. Shah S, Hegde BM, Wander GS, Anand MP, Mukherjee S, et al. (2007) Indian Hypertension Guidelines II. 2007: The Association of Physicians of India.
24. Tykarski A, Podolec P, Kopec G, Pajak A, Kawecka-Jaszcz K, et al. (2007) Polish Forum for Prevention Guidelines on Arterial Hypertension. Kardiol Pol 65: 1137-1141.
25. CPG Secretariat HU, Medical Development Division, Ministry of Health of Malaysia (2008) Clinical Practice Guidelines: Management of Hypertension.
26. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, et al. (2009) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32: 3-107.
27. Foundation NH (2010) Guide to management of hypertension 2008: Assessing and managing raised blood pressure in adults (Updated December 2010).
28. Rabi DM, Daskalopoulou SS, Padwal RS, Khan NA, Grover SA, et al. (2011) The 2011 Canadian Hypertension Education Program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of risk, and therapy. Can J Cardiol 27: 415-412, 415-433, e411-412.
29. Society SHM, (2011) Saudi Hypertension Management Society Guidelines: Synopsis 2011.
30. National Institute for Health and Clinical Excellence (2011) The Clinical Management of Primary Hypertension in Adults (CG127). August 2011: NICE.
31. Wright James M, Musini Vijaya M (2009) First-line drugs for hypertension. Cochrane Database Syst Rev: John Wiley & Sons, Ltd.
32. Mulrow Cynthia D, Chiquette E, Angel L, Cornell J, Summerbell Carolyn D, et al. (2000) Dieting to reduce body weight for controlling hypertension in adults. Cochrane Database Syst Rev.
33. Musini Vijaya M, Tejani Aaron M, Bassett K, Wright James M (2009) Pharmacotherapy for hypertension in the elderly. Cochrane Database Syst Rev: John Wiley & Sons, Ltd.
34. Alonso-Coello P, Irfan A, Sola I, Gich I, Delgado-Noguera M, et al. (2010) The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies. Qual Saf Health Care 19.
35. Burgers JS, Bailey JV, Klazinga NS, Van der Bij AK, Grol R, et al. (2002) Inside Guidelines. Diabetes Care 25: 1933-1939.
36. Ellis CJ, Legget ME, Edwards C, Van Pelt N, Ormiston JA, et al. (2011) High calcium scores in patients with a low Framingham risk of cardiovascular (CVS) disease: implications for more accurate CVS risk assessment in New Zealand. N Z Med J 124: 13-26.
37. Julius S, (2009) Tachycardia in hypertension: a saga of progress despite prejudice, confusion, and inertia. Prog Cardiovasc Dis 52: 26-30.
38. Elward KS, Simpson RJ Jr, Mendys P, (2010) Improving cardiovascular risk reduction for primary prevention-utility of lifetime risk assessment. Postgrad Med 122: 192-199.
39. White HD, (2011) Improving cardiovascular risk assessment. N Z Med J 124: 5-9.
40. Matheny M, McPheeters ML, Glasser A, Mercaldo N, Weaver RB, et al. (2011) Systematic Review of Cardiovascular Disease Risk Assessment Tools. Systematic Review of Cardiovascular Disease Risk Assessment Tools. Rockville (MD).
41. Ferket BS, Colkesen EB, Visser JJ, Spronk S, Kraaijenhagen RA, et al. (2010) Systematic review of guidelines on cardiovascular risk assessment: Which recommendations should clinicians follow for a cardiovascular health check? Arch Intern Med 170: 27-40.
42. Hodgkinson J, Mant J, Martin U, Guo B, Hobbs FD, et al. (2011) Relative effectiveness of clinic and home blood pressure monitoring compared with ambulatory blood pressure monitoring in diagnosis of hypertension: systematic review. BMJ 342: d3621.
43. Campbell F, Dickinson H, Cook J, Beyer F, Eccles M, et al. (2006) Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall. BMC Health Serv Res 6: 47.
44. Alderson PTT, (2011) Use of Cochrane Reviews in NICE clinical guidelines. The Cochrane Library Aug 10.
45. Morrison A MK, Clark M, Polisena J, Fiander M, Mierzwinski-Urban M, et al. (2009) English-Language Restriction When Conducting Systematic Review-based Metaanalyses: Systematic Review of Published Studies. Ottawa: Canadian Agency for Drugs and Technologies in Health.
46. Brouwers MC, Kho ME, Browman GP, Burgers JS, Cluzeau F, et al. (2011) The Global Rating Scale complements the AGREE II in advancing the quality of practice guidelines. Journal of Clinical Epidemiology.
47. Shekelle P, Eccles MP, Grimshaw JM, Woolf SH, (2001) When should clinical guidelines be updated? BMJ 323: 155-157.
48. Shekelle PG, Ortiz E, Rhodes S, Morton SC, Eccles MP, et al. (2001) Validity of the Agency for Healthcare Research and Quality clinical practice guidelines: how quickly do guidelines become outdated? JAMA 286: 1461-1467.
49. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, et al. (2003) Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206-1252.
50. World Health Organization ISoHWG (2003) 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. Journal of Hypertension 21: 1983-1992.
51. Oxman A, Fretheim A, Schunemann H, (2006) SURE (2006) Improving the use of research evidence in guideline development: introduction. Health Research Policy and Systems 4: 12.
52. Davis D, Goldman J, Palda V, (2007) CMA Handbook of Clinical Practice Guidelines. Canadian Medical Association.
53. National Institute for Health and Clinical Excellence (2009) The guidelines manual 2009.
54. Guidelines CoSfDTCP, Medicine Io (2011) Clinical Practice Guidelines We Can Trust; Graham R, Mancher M, Wolman DM, Greenfield S, Steinberg E, editors: The National Academies Press.
55. Scottish Intercollegiate Guidelines Network (2011) SIGN 50: A guideline developer's handbook.
56. Misso ML, Pitt VJ, Jones KM, Barnes HN, Piterman L, et al. (2008) Quality and consistency of clinical practice guidelines for diagnosis and management of osteoarthritis of the hip and knee: a descriptive overview of published guidelines. Med J Aust 189: 394-399.
57. The ADAPTE Collaboration (2009) The ADAPTE Process: Resource Toolkit for Guideline Adaptation. Version 2 ed.
58. Fervers B, Burgers JS, Voellinger R, Brouwers M, Browman GP, et al. (2011) Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation. Bmj Quality & Safety 20: 228-236.